(Total Views: 378)
Posted On: 05/07/2020 11:35:10 AM
Post# of 9144
I like this part!
"Promising early-stage technologies will initially move to Phase I, where NIH will make a modest award of funds while simultaneously supporting that inventor or company with technical and clinical experts, Collins said."
This may incentivise potential partners to license NNLX tech.
"Promising early-stage technologies will initially move to Phase I, where NIH will make a modest award of funds while simultaneously supporting that inventor or company with technical and clinical experts, Collins said."
This may incentivise potential partners to license NNLX tech.
(0)
(0)
